Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Idiopathic Interstitial Pneumonias

• FAPI PET for Lung Fibrosis
• Jin-shui Huan-xian Granule in the Treatment of IPF
• Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
• Genentech Xenon MRI Idiopathic Pulmonary Fibrosis
• A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough
• A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants
• Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis
• A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis
• Management of Progressive Disease in Idiopathic Pulmonary Fibrosis
• Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.
• GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis
• A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
• Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis
• A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)
• Inhaled NAC in Treatment of IPF
• Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
• To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers
• Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults
• A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
• An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis
• Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects
• JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
• Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
• The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
• Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
• This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.
• Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis
• Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
• Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).
• Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
• A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
• The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
• Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging
• Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea
• Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest
• Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension
• The Coagulation Cascade in Idiopathic Pulmonary Fibrosis
• Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial
• A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
• Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF
• Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
• Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
• CleanUP IPF for the Pulmonary Trials Cooperative
• Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
• Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
• A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)
• Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
• A Phase 2 Study of the Activity and Safety of KD025 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
• A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
• Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
• First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients
• All-Case Surveillance of Ofev in Patients With IPF in Japan
• A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination
• Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
• Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease
• Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF
• A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
• A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)
• 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis
• Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis
• A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
• Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
• Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects
• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis
• 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF
• RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients
• Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis
• Azithromycin in Idiopathic Pulmonary Fibrosis
• Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
• A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
• Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
• Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
• Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
• Nandrolone Decanoate in the Treatment of Telomeropathies
• Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
• Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
• Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
• Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
• A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
• Cromolyn Detection of Silent Aspiration
• Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)
• Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
• Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)
• A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
• To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
• A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
• Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)
• Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
• IPF Drug Deposition Study
• Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
• Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients
• STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis
• Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
• Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
• Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients
• Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.
• Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
• Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
• A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
• Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis
• Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)
• Safety and PK Study of BIBF 1120 in Japanese Patients With IPF
• Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis
• Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
• AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
• Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
• Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
• A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
• (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
• Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
• Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
• Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
• Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
• Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
• Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
• A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis
• SD, IL-13 Production Rate in IPF
• Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
• Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
• Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis
• Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
• BUILD 3: Bosentan Use in Interstitial Lung Disease
• Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
• Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
• Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
• Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
• Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
• Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis
• Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide
• Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study
• Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis
• Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis
• An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
• The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
• Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
• Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis
• An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
• A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)
• A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)